BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Drug Development

  Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting

  Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated the Phase III clinical study results for its non-surgical treatment candidate for cervical high-grade squamous intraepithelial lesions Cevira®.

  March 18, 2024

   · 

  5 min read
• CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

  CytoMed Therapeutics Limited has obtained board approval to launch, subject to certain terms and conditions, a pilot program to isolate and cryo-store peripheral blood mononuclear cells for and as a reward to loyal shareholders of CytoMed on a complimentary basis.

  March 18, 2024

   · 

  9 min read
• Business

  Dignify Therapeutics Announces Anthony DiTonno as Chief Executive Officer

  Dignify Therapeutics, a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, announced that Anthony DiTonno has been named as Chief Executive Officer.

  March 18, 2024

   · 

  2 min read
• Pharm Country

  Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

  Cambrex, a leading global contract development and manufacturing organization, announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.

  March 18, 2024

   · 

  2 min read
• BioMidwest

  The American Cancer Society and Color Health Announce Expansion of a Comprehensive Cancer Care Solution

  The American Cancer Society and Color Health announced an expansion of their program to form a comprehensive cancer solution for employers and labor unions to support their employee and member populations across all stages of the cancer journey.

  March 18, 2024

   · 

  6 min read
• SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

  SENISCA, an award-winning biotechnology company developing RNA-based senotherapeutics to treat age-related disease, announces it has raised an additional £3.7 million in funding.

  March 18, 2024

   · 

  4 min read
• Selvita launches biologic drug discovery and development services

  Selvita S.A. announced a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development, by adding comprehensive therapeutic antibody discovery and development capabilities to its portfolio.

  March 18, 2024

   · 

  4 min read